newsfilter
← Latest News
GlobeNewswire·

Kinnate Biopharma Inc. Reports Third Quarter 2021 Financial Results

In collaboration with Guardant Health, announced initial findings from BRAF Kinase Alteration Genomic Landscape and Real-World Clinical Outcomes Study Ended the quarter with cash, cash equivalents and investments of $347.9 million, exclusive of its Ch